Evidence map›Paper›PMID 21527521›Full record

ArticleBlood2011

Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2.

Olga Konopatskaya, Sharon A Matthews, Matthew T Harper, Karen Gilio, Judith M E M Cosemans, Christopher M Williams, Maria N Navarro, Deborah A Carter, Johan W M Heemskerk, Michael Leitges and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Platelet-Derived Extracellular Vesicles in Arterial Thrombosis.Advances in experimental medicine and biology · 2023
    Article
  5. mTOR regulates GPVI-mediated platelet activation.Journal of translational medicine · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Olga KonopatskayaSchool of Physiology & Pharmacology, Bristol Heart Institute, Bristol, United Kingdom.
Sharon A Matthews
Matthew T Harper
Karen Gilio
Judith M E M Cosemans
Christopher M Williams
Maria N Navarro
Deborah A Carter
Johan W M Heemskerk
Michael Leitges
Doreen Cantrell
Alastair W Poole
NIHR Bristol Cardiovascular Biomedical Research Unit · GBMaastricht University · NLUniversity of Dundee · GBUniversity of Oslo · NO

Funding

British Heart Foundation PG/07/118/24152British Heart Foundation PG/08/049/25130British Heart Foundation RG/05/015British Heart Foundation RG/10/006/28299Wellcome Trust 065975
6 · The paper itself

Abstract

Platelets are highly specialized blood cells critically involved in hemostasis and thrombosis. Members of the protein kinase C (PKC) family have established roles in regulating platelet function and thrombosis, but the molecular mechanisms are not clearly understood. In particular, the conventional PKC isoform, PKCα, is a major regulator of platelet granule secretion, but the molecular pathway from PKCα to secretion is not defined. Protein kinase D (PKD) is a family of 3 kinases activated by PKC, which may represent a step in the PKC signaling pathway to secretion. In the present study, we show that PKD2 is the sole PKD member regulated downstream of PKC in platelets, and that the conventional, but not novel, PKC isoforms provide the upstream signal. Platelets from a gene knock-in mouse in which 2 key phosphorylation sites in PKD2 have been mutated (Ser707Ala/Ser711Ala) show a significant reduction in agonist-induced dense granule secretion, but not in α-granule secretion. This deficiency in dense granule release was responsible for a reduced platelet aggregation and a marked reduction in thrombus formation. Our results show that in the molecular pathway to secretion, PKD2 is a key component of the PKC-mediated pathway to platelet activation and thrombus formation through its selective regulation of dense granule secretion.

Indexed as

AnimalsBlood PlateletsFemaleGene Expression Regulation, EnzymologicHumansIndolesMaleMaleimidesMiceMice, KnockoutPlatelet ActivationPlatelet AggregationProtein Kinase CProtein Kinase D2Protein Kinase InhibitorsProtein KinasesIndolesMaleimidesProtein Kinase CProtein Kinase D2Protein Kinase InhibitorsProtein Kinasesruboxistaurin

Identifiers

PMID21527521
PMCPMC4773892
OpenAlexW2139448535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.